AGMB Designs NOV-ERA Study
Agomab announces design of NOV-ERA Phase 2b study with Ontunisertib in Fibrostenosing Crohn's Disease
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.